From: Persistent polypharmacy and fall injury risk: the Health, Aging and Body Composition Study
Characteristics, Mean ± SD or N (%) | Fall injury (N = 545) | No Fall injury (N = 1219) |
---|---|---|
Age, years | 73.9 ± 3.0a | 73.5 ± 2.8 |
Women, N (%) | 357 (65.5%)b | 561 (46.0%) |
Black race, N (%) | 154 (28.3%)b | 508 (41.7%) |
Pittsburgh site, N (%) | 243 (44.6%)a | 464 (38.1%) |
Body mass index, kg/m2 | 26.7 ± 4.8b | 27.5 ± 4.7 |
Current smoker, N (%) | 39 (7.2%) | 116 (9.5%) |
Alcohol > 1 drink/week, N (%) | 257 (47.9%) | 609 (50.7%) |
≥ High school graduate, N (%) | 440 (81.6%)b | 872 (72.4%) |
Fall history, N (%) | 144 (26.6%)a | 242 (19.9%) |
Hypertension, N (%) | 311 (57.0%) | 695 (57.1%) |
Cardiovascular disease, n (%) | 91 (16.9%) | 208 (17.3%) |
Cerebrovascular disease, n (%) | 45 (8.3%) | 78 (6.5%) |
Diabetes, N (%) | 107 (19.7%) | 264 (21.8%) |
Cystatin C > 1.0, N (%) | 236 (44.0%) | 556 (46.0%) |
Poor vision, N (%) | 12 (2.2%) | 25 (2.1%) |
CES-D score | 4.6 ± 5.2 | 4.5 ± 5.2 |
3MSE score | 91.7 ± 6.9b | 90.3 ± 8.1 |
Knee or leg pain, N (%) | 181 (33.3%) | 379 (31.2%) |
1.4 g Monofilament insensitivity, N (%) | 207 (38.8%) | 421 (35.1%) |
6-m Gait speed, m/second | 1.2 ± 0.2 | 1.2 ± 0.2 |
Number of medications | ||
 1998/99 clinic visit | 3.5 ± 2.7a | 3.0 ± 2.6 |
 1999/00 clinic visit | 3.7 ± 2.9b | 3.3 ± 2.7 |
 2001/02 clinic visit | 4.3 ± 3.1b | 3.7 ± 2.7 |
 2002/03 clinic visit | 4.5 ± 3.2b | 4.0 ± 2.9 |
 2004/05 clinic visit | 5.1 ± 3.3a | 4.6 ± 3.2 |
 2006/07 clinic visit | 5.7 ± 3.3a | 5.0 ± 3.5 |
 2007/08 clinic visit | 5.9 ± 3.7a | 5.3 ± 3.6 |
Use of ≥1 FRID, N (%) | ||
 1998/99 clinic visit | 126 (23.1%)b | 201 (16.5%) |
 1999/00 clinic visit | 142 (26.0%)b | 220 (18.1%) |
 2001/02 clinic visit | 157 (28.8%)b | 252 (20.7%) |
 2002/03 clinic visit | 158 (29.0%)b | 270 (22.1%) |
 2004/05 clinic visit | 122 (22.4%)b | 232 (19.0%) |
 2006/07 clinic visit | 109 (20.0%)b | 211(17.3%) |
 2007/08 clinic visit | 102 (18.7%)b | 196 (16.1%) |